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Introduction: Post endodontic pain is often linked to the inflammatory process as well as
additional central mechanisms. The purpose of the present double-blind randomized clinical
trial study was to compare the prophylactic effects of a derivative of Zingiber Officinale,
Zintoma, and Ibuprofen on post endodontic pain of molars with irreversible pulpitis.
Materials and Methods: The post endodontic pain of 72 enrolled patients suffering from
irreversible pulpitis was assessed after prophylactic use of 400 mg Ibuprofen, 2 gr Zintoma and
placebo. Using the Heft-Parker Visual Analogue Scale, the patients recorded their perceived
pain before taking the medicament (baseline), immediately after and also at 4, 8, 12, 24, 48,
and 72 h post one-visit endodontic treatment. The statistical analysis was done using Kruskal-
Wallis, Mann-Whitney, and Freedman tests (P<0.05). Results: At all times, there was
significant difference between the Ibuprofen and Zintoma (P<0.05) and also between the
Ibuprofen and placebo (P<0.05). However, there was no significant difference between
Zintoma and the placebo in any of time intervals (P>0.05). No side effects were observed.
Conclusion: The obtained results of the trial revealed that prophylactic use of 2 gr Zintoma is
not an effective pain relieving agent.
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ain control during and after endodontic treatment is
one of the most important issues in endodontics [1, 2].
It has a high occurrence of 25-40% [3, 4]. Several
factors influence this pain: the pulpal status, patients’
anxiety, existence of pretreatment pain, and manipulation of
periapical tissues [3, 5-8]. Pain following endodontic therapy
is often linked to the inflammatory process as well as
additional central mechanisms [9, 10]. Many medications are
prescribed in dentistry to control/reduce the pain. These
drugs/materials include opioid and non-opioid analgesics,
non-steroidal anti-inflammatory drugs (NSAIDs), benzo-
diazepines and corticosteroids, and even MTA. [7, 11-16].
NSAIDs are generally considered to be the most
effective treatment for inflammation and hence
inflammatory pain. However, the many adverse effects, most
important of which are gastrointestinal and cardiovascular,
may outweigh the benefits [17]. That is why an increasing
numbers of patients are searching for alternative forms of
pain management, with minimal side effects. Zingiber
officinale (Z.officinale), commonly known as ginger is an
anti-inflammatory agent for musculoskeletal diseases.
Recently, there has been a lot of research performed on using
the active ingredients of ginger and understanding it
pharmacological effects in patients [18]. Z.officinale is a
complex mixture of pharmacological compounds containing
several hundred known constituents, including gingerols,
beta-carotene, capsaicin, caffeic acid, curcumin, and
salicylate [18-20]. It has been suggested that some of its
chemical constituents, including gingerols, shogaols,
paradols, and zingerone, have demonstrated anti-
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inflammatory actions, inhibiting leukotriene synthesis, as
well as the activity of cyclooxygenase enzymes (COX-1 and
COX-2), production of interleukins (Il-1 and Il-12), [21]. In
addition, it has been suggested that Z.officinale and it’s
constituents-particularly shogaols-have agonize vallinoid
(capsaicin) receptors TRPV1, which are involved in the
central and peripheral processing of noxious stimuli [18].
There are a lot of studies conducted on the prophylactic
effects of the prescribed chemical drugs on post endodontic
pain [12, 13, 22], in which there has not been dealt with
herbals such as Zintoma. Direct and indirect capabilities of Z.
Officinale for pain management are well documented [18,
21]; therefore, this randomized double-blind clinical trial
study was designated to compare the prophylactic effect of
Zintoma (a derivative of Ginger) and Ibuprofen on post
endodontic pain related to one-step treatment of molar teeth
with irreversible pulpitis.
Material and Methods
This study has been independently reviewed and approved by
the ethics committee of Babol University of Medical Sciences
(Ethical Code: 91-3013), and has been submitted on the
website of Iranian Registry of Clinical Trial (ID No:
IRCT138903174116N1). The initial sample size has been
determined based on the power of 0.9 and the type I error of
0.05, with 30 subjects in each group (totally 90). The inclusion
criteria included: healthy persons (ASA I or II), age 18 to 65,
active pain in one of the mandibular molars, prolonged pain to
cold test, spontaneous pain reported (at least 54 based on Heft-
Parker Visual Analogue Scale (VAS), normal priapical view on
radiographs, the patients ability in reading, comprehending
and filling out the VAS form. The samples with the following
criteria were excluded from the study: pain in more than one
tooth, the existence of contributory medical history, allergy to
lidocaine, NSAIDs or ginger, pregnancy or lactation, use of
any sedatives or analgesics within the past 24 h, non-restorable
tooth, tooth that was over instrumented or overfilled during
treatment and where the patient was unable to comprehend
the protocol of the study or sign the informed consent. The
clinical diagnosis of irreversible pulpitis was done through the
intense or prolonged reaction to cold stimuli(Roeko; Coltene
Whaledent, Langenau, Germany) for at least 10 sec, and the
existence of reaction to the electric pulp tester (Element
Diagnostic Unit; SybronEndo, Glendora, CA).
After explaining the nature, purpose of the study and
any probable risk and side effects of drug/treatment to the 90
participants, the written informed consent was obtained.
Before taking the drugs, the patients were asked to record
their pain intensity based on VAS as baseline, which was
taught to the participants. Afterwards, the patients were
randomly aligned into 3 groups of Ibuprofen, Zintoma, and
placebo, using the “simple randomized allocation” method. It
means each subject entering our study was allotted to one
group by sequence.
The three drugs had been prepared by a pharmacologist
in the same color and size capsules made of hard gelatin, and
put in similar specially encoded pockets. The pharmacologist
was in charge of encoding the capsules, in a way that neither
the operator (Final year postgraduate student of
Endodontics) nor the patient was informed of the drug.
According to the group dedicated, each of the subjects was
given a pack of the drugs along with Acetaminophen 325 mg
(Aria Pharmaceutical Co, Tehran, Iran). The design of using
drug for each group was as follows:
Ibuprofen Group: 1.5 h before the treatment, 2 placebo
capsules and 0.5 h before the treatment, 2 capsules, one of
which including placebo and the other having 400 mg
Ibuprofen (Hakim Pharmaceutical Co, Tehran, Iran).
Placebo capsules were given in this group to mirror the
number of capsules given in the Zintoma group.
Zintoma Group: 1.5 and 0.5 h before the treatment, each
time two 500-mg capsules of Zintoma (totally 2 g) given.
Active ingredient in each 500-mg capsule is 2.5 mg,
(Goldarou Pharmaceutical Co, Isfahan, Iran).
Placebo Group: 1.5 and 0.5 h before the treatment, each time
2 placebo capsules (Lactose powder) were given to the
participants.
In case of the rescue drug (acetaminophen), the patients
were asked to record the time and amount taken. All the
patients were treated by one practitioner who was a final year
postgraduate student of endodontics from September 2010
until April 2011.
Half an hour after taking the second dosage of the drug,
one cartridge of anesthetic solution including 2% lidocaine
with epinephrine 1:200000 (Persocaine-E; Darupakhsh,
Tehran, Iran) was injected for inferior alveolar nerve block
(IANB). Root canal therapy started 15 min after anesthesia
injection, if lip numbness had been obtained as the first sign of
IANB success; otherwise the same injection was repeated. If
the patient had recorded any pain or sensitivity to cold after
IANB and before the start of endodontic therapy or any time
during the treatment, complementary anesthesia techniques
(buccal infiltration, intraligamentary and eventually
intrapulpal injection respectively) were used. After preparing
the access cavity, isolation with rubber dam and canal
negotiation, working length determination was performed
with apex locator (Root ZX, Morita Corporation, Tokyo,
Japan) and was verified through PA radiography taken with
bisected technique (1 mm shorter than radiographic apex).
The primary canal cleaning and shaping was done by #10 and
#15 K-Files (Dentsply Maillefer, Ballaigues, Switzerland) and
#20, 25 and 30 K-Flex files (Kerr/Sybron, Romolus, MI) in
pressurless crown-down technique. Canal irrigation was
performed with 2.5 % NaOCl. The coronal areas of the canal
were enlarged with #2 and #3 Gates Glidden and then #15 to
#35 Mtwo rotary files, canals were prepared sufficiently. After
completion of cleaning and shaping, the canals were dried with
paper point (Aria Dent, Tehran, Iran) and filled with
nonstandard gutta-percha (Meta Dental Corp., Chungju,
Korea) and sealer AH26 (Dentsply DeTrey, Konstanz,
Germany)with cold lateral condensation technique.
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Table 1. The number of the patients in each group, gender distribution, average age, type of tooth, and initial pain score
Group(n) Age (year)[Mean (SD)]
Gender (n) Molar (n) Initial Pain Score
Mean (SD)Male Female First Second Third
Ibuprofen (27) 34.31 (10.35) 15 12 10 10 7 83.63 (20.48)
Zintoma (24) 35.96 (9.89) 13 11 9 7 8 86.41 (22.78)
Placebo (21) 35.94 (9.99) 10 11 8 8 5 90.11 (21.72)
Total (72) P = 0.61
Figure 1. Pain reduction in three groups
The access cavity was sealed with the temporary
restoration (Coltosol; Asiachimi-Teb, Tehran, Iran) and
patient was referred for the permanent filling of the tooth.
The VAS form was filled out by the patients
immediately after temporization and then in 4, 8, 12, 24, 48,
and 72 h, subsequently. Moreover, they were asked to fill out
another form to record the time and amount of rescue
(acetaminophen), if they had used it. The patients who had to
take analgesic other than acetaminophen, because of intense
pain or any other, were omitted from the study and replaced
with other ones.
The data were analyzed through software SPSS 16 and
Kruskal-Wallis, Mann-Whitney, and Freedman tests. The
level of significance was 0.05. It also should be mentioned
that there was no conflict of interest in this study.
Results
Out of 90 patients entering this study, only 72 patients (80%)
returned the questionnaires regarding post endodontic pain,
meaning that the rest 18 subjects were lost to follow. The data
related to number, age, gender, type of tooth, and initial pain
score of each group has been shown in the Table 1.
There was no significant difference observed in terms of
age, gender, the number of the first, second, and third molars
in any of the groups and initial pain score (P>0.05).
Furthermore, there was no significant correlation between
gender and tooth type with perceived post endodontic pain.
At all times there was significant difference between
three groups (P<0.05). In the two by two comparison
between the groups at all times, the significant statistical
difference was seen between the Ibuprofen and the Zintoma
groups (P<0.05) and Ibuprofen and the Placebo groups
(P<0.05). The pain score difference in each group was
significant in different times (P<0.0001) (Figure 1).
The perceived pain by the patients in each of the three
groups had been significantly reduced after the endodontic
treatment (P<0.05). There was no significant statistical
difference observed as a result of taking acetaminophen by
the patients in the three groups (P>0.05). Statistical analysis
related to the rescue drug (Acetaminophen) showed no
significance (P>0.05).
Discussion
Having assessed the tools for pain analysis, Coll et al. showed
the appropriateness of the numerical VAS [23]. This scale is a
100 mm axis on which 0 indicates no pain and 100 shows the
maximum pain possible. Numerical VAS is simply applied,
analyzed and repeated. Moreover, it is not affected by the
gender of the patient [24]. The second pain analysis scale is
categorical VAS, which has five groups of pain including
none to mild, mild to moderate, moderate to strong, strong
to intense and intense to maximum possible. The first section
itself is divided into faint and weak subgroups. Although
simple, this scale is reliable and repetitive; but, each group of
it contains great spectrum of pain intensity and quality [25].
Hence, the third scale, Heft-Parker VAS which is actually the
combination of the first two ones, was introduced [23, 24]. In
the present research, Heft-Parker VAS was applied to
estimate the patient’s pain, before and after the endodontic
treatment. Most of the previous studies had also used this
scale to analyze the pain perception of the patients [3, 4, 12,
17, 26-28].
Besides responding to the cold test and electric
sensitivity for clinical determination of the pulp status,
bleeding or not, after the preparation of the access cavity, is
considered as the golden standard in the pulp status
diagnosis [29-34]. In this research, visual inspection and the
existence of bleeding after the access cavity preparation was
applied to confirm the pulp vitality, and consequently the
patients whose tooth pulp showed no pulp bleeding were
omitted from the study.
Some chemicals such as drugs from benzodiazepines,
non-opioid analgesics, and opioids groups have been utilized
prophylactically to decrease post endodontic pain, among
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which, NSAIDS, especially Ibuprofen has a noticeable role
[26-28, 35, 36]. Having analyzed different dosages of
Ibuprofen, Seymour et al. had concluded that a dosage of 600
mg has the highest effect as a painkiller in comparison with
the dosages 200 and 400 mg [37].
Although in this research, like the Seymour’s trial there
was just a single dosage of Ibuprofen (400 mg) analyzed, the
acceptable effect of the drug, was also determined. In the
study by Attar et al., a single dosage of 600 mg Ibuprofen had
reduced the post endodontic pain more than the placebo,
which is in line with the result of this research [35]. In a
study by Gheshlaghi Azar and Kheradmand, the effect of
celecoxib on pain reduction in endodontic treatment was
even more than Ibuprofen [6]. But in our study, Zintoma was
less effective than Ibuprofen. It should be mentioned that in
the study by Gheshlaghi Azar, apart from the teeth with
irreversible pulpitis, the necrotic teeth were also analyzed.
Besides, in the study by Menke et al, 600 mg Ibuprofen had
reduced post endodontic pain more than 400 mg Etodolac
[38]. Of course, in the last two studies, the necrotic teeth
were also included. The result of study done by Ehsani et al,
to assess the role of prophylactic Ibuprofen and N-
acetylcysteine (NAC) on the level of cytokines in periapical
exudates and the post-treatment pain, showed that NAC can
be a substitute for Ibuprofen in the management of post
endodontic pain [39], whereas in our study, Ibuprofen was
significantly more effective than the study drug. In another
study for assessment of prophylactic effect of
intraligamentary injection of 0.4 mL piroxicam (feldene) for
the management of post-endodontic pain in molar teeth with
irreversible pulpitis, the decrease in the intensity of post-
treatment pain between the groups of piroxicam and placebo
(same amount of lidocaine) was very significant [9]. In the
study of Arslan et al, done to evaluate effectiveness of
tenoxicam and Ibuprofen for pain prevention following
endodontic therapy in comparison to placebo, prophylactic
administration of a single dose of 20 mg tenoxicam or 200
mg Ibuprofen before root canal therapy provides an effective
pain reduction at 6 h. Superiority of Ibuprofen to placebo
was also confirmed in present research. Because of the
advantages of tenoxicam, the authors suggested it may be
useful as a prophylactic analgesic when post-endodontic pain
is anticipated [12], whereas Zintoma did not show
effectiveness for pain relief in our trial may be due to its short
-term usage. In another study done by Rogers et al, to
compare the effect of intracanal use of ketorolac
tromethamine and dexamethasone with oral Ibuprofen on
post endodontic pain, no significant differences were
demonstrated between Ibuprofen and either dexamethasone
or ketorolac tromethamine which prophylactically had been
used intra canal. Although Ibuprofen pain ratings were less
than the placebo at all-time points [22], that is in line with
the results of the present study.
In the research done by Jalalzadeh et al, the prophylactic
effect of prednisone was compared to placebo in terms of the
endodontic pain, in which prednisone was more effective [4].
Mehrvarzfar et al. assessed the effect of supraperiosteal
injection of dexamethasone on postoperative pain. According
to their results, dexamethasone was considerably effective on
controlling the severity of pain during the first 24 h; in
contrast, there was no difference between dexamethasone and
placebo groups 48 h after the first appointment. They
concluded that a single dose of dexamethasone infiltrated
around the apex of a tooth with irreversible pulpitis could be
effective in reduction or prevention of postoperative
endodontic pain during the first 24 h [40]. Up together, the
noticeable differences observed in previously-mentioned trials
are not unusual, probably because of different setting in case of
drug dose, teeth involved, sample size etc.
In our electronic search, all of the previous well-
documented researches found regarding the analgesic effect
of Z.Officinale were related to either clinical chronic or
experimentally induced acute pains, none of which had been
conducted to assess the analgesic effect of Z.Officinale in
dental practice, [41-46]. That is why we conducted the
present study as the first academic trial in dentistry field to
evaluate the analgesic effect of Z.Officinale on acute pain
resulted from pulpitis.
Zintoma is an analgesic that is highly applied in medical
science and has the least side effects. In most of the previous
studies carried out on Zintoma such as the studies by
Haghighi et al., Altman et al. and Bliddal et al., chronic use of
the drug had significant difference with Ibuprofen in
reducing the pain caused by osteoarthritis [41-43].
In this study, which aimed at analyzing the short-term
effect of Zintoma, it could not present its anti-inflammatory
and hence painkilling effect, and that can be why the findings
indicated that the effect of Zintoma on post endodontic pain
had no significant difference with the placebo. Another
reason to mention for the little effect of Zintoma is related to
the formation and continuation of all the inflammatory
pains, such as the pain caused by tooth pulpitis, there have
been a set of inflammatory mediators such as prostaglandins,
serotonin, and histamine, with their synergic effect on each
other [47, 48]. However, a drug such as Zintoma, that reduce
the production of new mediators which are specially of
prostaglandin type, not only doesn’t prevent the action of
previously-existent mediators of any type, but also are less
effective on the activity of other types of inflammatory
mediators, and as a result, might have no significant effect on
the reduction of inflammatory pain. Hence, the patients who
have the inflammatory pain, before the embark of the
treatment, may use less prophylactic effect of this anti-
inflammatory drugs, in short period, in comparison with
those who don’t have the pain beforehand. This could be one
of the reasons for the difference observed between the results
of the various studies. In the present study, the hand and
rotary instruments were applied using crown-down
technique. Since among of the effective factors on the post
endodontic pain is the extruded debris behind the apex. It
has been shown that this technique would lead to the lesser
extrusion of the debris behind the apex [49].
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It should be mentioned that use of placebo in this study
had no conflict with ethical issues; since all the patients were
informed of the procedure. Furthermore, it has been
scientifically proved that the placebo along with the full
pulpectomy of the teeth could cause pain reduction to 71%
[35]. In the present research, the patients were monitored for
72 h and there was no side effects reported for Zintoma.
Due to a paucity of well-conducted trials, evidence of
the efficacy of Z. officinale to treat pain remains insufficient.
However, the available data provide tentative support for the
anti-inflammatory role of Z. officinale constituents, which
may reduce the subjective experience of pain in some
inflammatory conditions. Further trials, particularly in
dentistry field, therefore, seem to be warranted.
Conclusion
Regarding the results of this double-blind randomized
clinical trial study, it can be concluded that the drug regimen
of Zintoma (1 gr, 1.5 h and 1 gr, 0.5 h prior to commence of
endodontic treatment is not effective for post-treatment pain
relief in molar teeth with irreversible pulpitis. It is
recommended that further studies be done as for this drug,
so that an appropriate dosage of Zintoma could be
determined for endodontic treatments.
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